Toxicological Assessment of LN20188, a Botanical Combination of Withania somnifera Root and Abelmoschus esculentus Fruit Extracts
BioMed Research International · 2026-01 · 2026 (1)
DOI: 10.1155/bmri/6355273 ↗Kurz gefasst
Fachartikel in der Zeitschrift BioMed Research International, online erschienen am 31.03.2026. Verfasst von Ravikumar Madireddy und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Toxicology, Laila Nutra Private Limited, R&D Centre, Vijayawada, Andhra Pradesh, India. Hauptthemen laut MEDLINE: Plant Extracts, Withania, Plant Roots, Fruit. Die Arbeit nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Laila Nutraceuticals.
Abstract (Originalsprache)
LN20188 is a botanical combination composed of extracts derived from Withania somnifera (L.) Dunal root and Abelmoschus esculentus (L.) Moench fruit. Our earlier investigations revealed the benefits of LN20188 in promoting gut motility and reducing constipation. The current investigation presents the toxicological profile of LN20188 following OECD guidelines for chemical testing. In an acute oral toxicity (AOT) study involving Sprague Dawley rats, no significant signs of toxicity or morbidity were observed, and the lethal dose (LD 50 ) was determined to be greater than 2000 mg/kg body weight (b.w). Gross pathological findings further confirmed the safety of LN20188. In a repeated‐dose subchronic toxicological investigation, rats were administered either 500, 1000, or 1500 mg/kg b.w of LN20188 for 90 consecutive days. LN20188 was found to be safe, where data on body weight, food consumption, organ weights, hematology, clinical biochemistry, and biomarkers were comparable to those of vehicle controls. The estimated no‐observed‐adverse‐effect level (NOAEL) for LN20188 in male and female rats is determined to be 1500 mg/kg b.w. Genotoxicity studies, including bacterial reverse mutation, in vitro chromosomal aberration (CA), and in vivo micronucleus test (MNT) in mouse bone marrow erythrocytes, indicated no clastogenic or mutagenic activity. Results of the bacterial reverse mutation assay showed that LN20188 did not exhibit a notable increase in colony count (mutagenicity) up to 5000 μ g/plate. In CA assay, LN20188 concentrations of up to 1000 μ g/mL in the short term and 500 μ g/mL in continuous exposure did not induce any chromosomal aberrations. Additionally, in vivo MNT showed that LN20188, up to 2000 mg/kg b.w, did not elevate the frequency of micronucleated PCEs (MNPCEs). Overall, these studies demonstrate that oral administration of LN20188 does not result in toxicity or genotoxic effects.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Toxicology, Laila Nutra Private Limited, R&D Centre, Vijayawada, Andhra Pradesh, India.
- Department of Pharmacology & Medical Affairs, Laila Nutra Private Limited, R&D Centre, Vijayawada, Andhra Pradesh, India.
ORCID-Profile: Ravikumar Madireddy, Sundararaju Dodda, Gopichand Chinta, KrishnaRaju Venkata Alluri
Förderung
- Laila Nutraceuticals
Zitieren
APA
Madireddy, R., Dodda, S., Chinta, G., & Alluri, K. V. (2026). Toxicological Assessment of LN20188, a Botanical Combination of Withania somnifera Root and Abelmoschus esculentus Fruit Extracts. BioMed Research International, 2026(1). https://doi.org/10.1155/bmri/6355273
Vancouver
Madireddy R, Dodda S, Chinta G, Alluri KV. Toxicological Assessment of LN20188, a Botanical Combination of Withania somnifera Root and Abelmoschus esculentus Fruit Extracts. BioMed Research International. 2026;2026(1). doi:10.1155/bmri/6355273
BibTeX
@article{Madireddy2026,
author = {Madireddy, Ravikumar and Dodda, Sundararaju and Chinta, Gopichand and Alluri, KrishnaRaju Venkata},
title = {Toxicological Assessment of LN20188, a Botanical Combination of Withania somnifera Root and Abelmoschus esculentus Fruit Extracts},
journal = {BioMed Research International},
year = {2026},
volume = {2026},
number = {1},
doi = {10.1155/bmri/6355273}
}
EUVIMED